Tadashi Terui
18PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (18)
Sort by Publication Date:
|Dec 12, 2025
Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial.Tadashi Terui, Yukari Okubo, Satomi Kobayashi
|Oct 15, 2024
Authors' Reply to Wang et al., "Comment on 'Efficacy and Safety of Brodalumab, an Anti‑interleukin‑17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16‑Week Results of a Randomized Clinical Trial'".Yukari Okubo, Satomi Kobayashi, Masamoto Murakami
|Jul 02, 2024
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial.Yukari Okubo, Satomi Kobayashi, Masamoto Murakami
|Jun 19, 2024
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study.Yukari Okubo, Tadashi Terui, Satomi Kobayashi
|Dec 07, 2023
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.Tadashi Terui, Yukari Okubo, Satomi Kobayashi
|Sep 21, 2023
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study.A David Burden, Robert Bissonnette, Alexander A Navarini
Pageof 3
Frequent Collaborators
9 joint publications
Hideki Fujita
7 joint publications
Koremasa Hayama
6 joint publications
Yukari Okubo
5 joint publications
Akimichi Morita
4 joint publications
Masamoto Murakami
3 joint publications
Yayoi Tada
3 joint publications
Natsumi Ikumi
2 joint publications
Yusuke Niwa
2 joint publications
Shigetoshi Sano
2 joint publications
Yoshiumi Ouchi
